<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ayu</journal-id><journal-id journal-id-type="iso-abbrev">Ayu</journal-id><journal-id journal-id-type="publisher-id">AYU</journal-id><journal-title-group><journal-title>Ayu</journal-title></journal-title-group><issn pub-type="ppub">0974-8520</issn><issn pub-type="epub">0976-9382</issn><publisher><publisher-name>Medknow Publications &#x00026; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23559794</article-id><article-id pub-id-type="pmc">3611636</article-id><article-id pub-id-type="publisher-id">AYU-33-224</article-id><article-id pub-id-type="doi">10.4103/0974-8520.105242</article-id><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group></article-categories><title-group><article-title>Clinical efficacy of <italic>Shodhana Karma</italic> and <italic>Shamana Karma</italic> in <italic>Mandala Kushtha</italic> (Psoriasis)</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mangal</surname><given-names>Gunjan</given-names></name><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name><surname>Mangal</surname><given-names>Gopesh</given-names></name><xref ref-type="aff" rid="aff2">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>Radhey Shyam</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib></contrib-group><aff id="aff1">Lecturer, Department of Swasthavritta, Sri Shirdi Sai Baba Ayurvedic College, Renwal, Jaipur, Rajasthan, India</aff><aff id="aff2"><label>1</label>Lecturer, Post Graduate Department of Panchakarma, National Institute of Ayurveda, Jaipur, Rajasthan, India</aff><aff id="aff3"><label>2</label>Vice Chancellor, Rajasthan Ayurveda University, Jodhpur, Rajasthan, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Gopesh Mangal, Lecturer, P.G. Department owf Panchakarma, National Institute of Ayurveda, Madhav Vilas Palace, Amer Road, Jaipur &#x02013; 302002, Rajasthan, India. E-mail: <email xlink:href="ayurexpert@gmail.com">ayurexpert@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Apr-Jun</season><year>2012</year></pub-date><volume>33</volume><issue>2</issue><fpage>224</fpage><lpage>229</lpage><permissions><copyright-statement>Copyright: &#x000a9; AYU (An International Quarterly Journal of Research in Ayurveda)</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>In India an estimated 0.8% of the population is suffering from Psoriasis. It is a papulo-squamous disorder of the skin, characterized by sharply defined erythemato-squamous lesions. It is chronic and is well known for its course of remissions and exacerbations. The exact etiology is still unknown. This condition is comparable with <italic>Mandala Kushtha</italic> in Ayurvedic system of medicine. <italic>Shodhana</italic> procedures are reliable to control the disease. Forty patients, fulfilling the inclusion criteria, were selected and randomly divided into four groups with 10 patients in each group. In Group A, <italic>Vamana</italic> and <italic>Virechana</italic> was administered once during the trial period. In Group B, <italic>Vamana</italic> and <italic>Virechana</italic> followed by Dermo-care in the dose of 5 g twice a day for the period of 2 months. In Group C, only Dermo-care was administered. In Group D, Tab. Neotrexate (Methotrexate) 7.5 mg/week was given under the supervision of dermatologist. Marked improvement was observed in 10% of the patients in Group B. Moderate improvement was observed in 20% of the patients in Group A, 90% in Group B, and 80% in Group D. Mild improvement was observed in 80% of the patients in Group A, 100% in Group C, and 20% in Group D.</p></abstract><kwd-group><kwd><italic>Mandala Kushtha</italic></kwd><kwd>Psoriasis</kwd><kwd><italic>Shamana</italic></kwd><kwd><italic>Shodhana</italic></kwd><kwd><italic>Vamana</italic></kwd><kwd><italic>Virechana</italic></kwd></kwd-group></article-meta></front><body><sec id="sec1-1"><title>Introduction</title><p>In Ayurveda all skin diseases are categorized under &#x0201c;<italic>Kushtha</italic>&#x0201d;. <italic>Mandala Kushtha</italic> a type of <italic>Maha Kushtha</italic> is a chronic of <italic>Kushtha</italic>. Even if it is cured relapses are common. <italic>Mandala Kushtha</italic> is stated to be <italic>Tridoshaja</italic> with the dominance of <italic>Kapha Dosha</italic>. The description and characteristic features of <italic>Mandala Kushtha</italic> are nearer to Psoriasis. Hence, <italic>Mandala Kushtha</italic> can be compared with Psoariasis.</p><p>Psoriasis is chronic and well known for its course of remissions and exacerbations. Modern medical science treats psoriasis with spiraled (P) and ultraviolet A (UVA) therapy PUVA, corticosteroids, and antimitotic drugs. But these therapies are associated with serious side effects like liver and kidney failure, bone marrow depletion, etc.[<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref>]</p><p>Panchakarma therapy of Ayurveda has attracted attention of the people worldwide as it is an unique sort of treatment of various chronic, auto immune, hormonal, degenerative disorders, etc., where other sorts of treatments have no satisfactory answer. Acharya Charaka has highlighted the role of Panchakarma therapy by stating that the disease treated by <italic>Shodhana</italic> will never recur, whereas the treatment with <italic>Shamana</italic> therapy may recur in due course of time.[<xref ref-type="bibr" rid="ref3">3</xref>]</p><p>In addition, if <italic>Shamana</italic> drugs are administered after proper course of <italic>Shodhana</italic>, then it provides additional relief and thus helps in eradicating the diseases completely.</p><p><italic>Vamana Karma</italic> is the best measure for <italic>Kapha Dushti</italic>, whereas <italic>Virechana Karma</italic> is indicated not only for <italic>Pitta Dosha</italic> but also in <italic>Kapha</italic> and <italic>Rakta Dushti</italic>.</p><p><italic>Jeemutaka</italic> (<italic>Luffa echinata</italic>) is selected for <italic>Vamana</italic> instead of <italic>Madana Phala</italic> (<italic>Randia spinosa</italic>) as it is specially indicated in <italic>Kushtha Roga</italic>.[<xref ref-type="bibr" rid="ref4">4</xref>]</p><p>Considering all the above, it has been planned to evaluate comparative efficacy of <italic>Vamana</italic>, <italic>Virechana</italic> and <italic>Shamana Yoga</italic> (Dermo-care) [<xref ref-type="table" rid="T1">Table 1</xref>] in <italic>Mandala Kushtha</italic> (Psoriasis).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Ingredients of Dermo-care (per 5 g)</p></caption><graphic xlink:href="Ayu-33-224-g001"/></table-wrap></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><sec id="sec2-1"><title>Study design</title><p>An open prospective clinical trial.</p></sec><sec id="sec2-2"><title>Patients</title><p>Patients suffering from <italic>Mandala Kushtha</italic> fulfilling the inclusion criteria were randomly selected from the Out-Patient Department (OPD) and the In-Patient Department (IPD) section of National Institute of Ayurveda, Jaipur and Girdhara Hospital and Research Centre, Jaipur. Total 47 patients were registered in the trial, out of which 40 patients were completed course of treatment.</p></sec><sec id="sec2-3"><title>Inclusion criteria</title><p>
<list list-type="bullet"><list-item><p>Patients aged between 12 and 60 years.</p></list-item><list-item><p>Patients having the clinical features of <italic>Mandala Kushtha</italic> (Psoriasis).</p></list-item></list></p></sec><sec id="sec2-4"><title>Exclusion criteria</title><p>
<list list-type="bullet"><list-item><p>Patients aged below 12 and above 60 years.</p></list-item><list-item><p>Patients with leprosy, tuberculosis, paralysis, and malignant diseases.</p></list-item><list-item><p>Pregnant women and lactating mothers.</p></list-item><list-item><p>Patients with systemic disorders viz. uncontrolled hypertension, cardiac problems, diabetes mellitus, etc.</p></list-item><list-item><p>Patients who are on steroids.</p></list-item></list></p></sec><sec id="sec2-5"><title>Plan of study</title><p>Registered patients were equally categorized in to four groups (10 in each group).</p><p>Group A: Vamana and Virechana</p><p>Group B: Vamana and Virechana followed by administration of Dermo-care (Anubhuta Yoga)</p><p>Group C: Only Dermo-care</p><p>Group D: Tab. Neotrexate (Methotrexate 7.5 mg/week)</p></sec><sec id="sec2-6"><title>Posology and duratrion of treatment</title><p>
<list list-type="bullet"><list-item><p>The trial drug, Dermo-care [<xref ref-type="table" rid="T1">Table 1</xref>] &#x02013; For the present clinical research work, a hypothetical indigenous herbo-mineral compound is prepared in <italic>Churna</italic> (powder) form was administered 5 g after meal, twice a day with potable water for a period of 2 months.</p></list-item><list-item><p>Standard control drug, Tab. Neotrexate (Methotrexate) 7.5 mg/week (2.5 mg for three times at 12 hourly &#x02013; 8 pm-8 am-8 pm/week) with potable water for 2 months. The drug was administered under the supervision of a dermatologist.</p></list-item><list-item><p>Follow up was done for 2 months at regular interval of 15 days.</p></list-item></list></p></sec><sec id="sec2-7"><title>Treatment schedule</title><sec id="sec3-1"><title>Vamana procedure</title><p>
<list list-type="order"><list-item><p><italic>Koshtha Pareeksha</italic> was done with <italic>Triphala Churna</italic> (10 g) in morning with luke warm water for 1 day.</p></list-item><list-item><p><italic>Deepana, Pachana</italic> with <italic>Panchakola Churna</italic> (5 g) twice a day for 2 days or till appearance of <italic>Nirama Lakshana</italic>.</p></list-item><list-item><p><italic>Snehapana</italic>[<xref ref-type="bibr" rid="ref5">5</xref>]: <italic>Panchatikta Ghrita</italic>[<xref ref-type="bibr" rid="ref6">6</xref>] was administered for the purpose of <italic>Snehapana</italic> orally.</p></list-item><list-item><p><italic>Abhyanga</italic> and <italic>Swedana</italic> &#x02013; <italic>Sarvanga Abhyanga</italic> by <italic>Dashamoola Tail</italic> and <italic>Sarvanga Swedana</italic> by the <italic>Dashamoola Kwatha</italic> was done.</p></list-item></list></p></sec><sec id="sec3-2"><title>Vamana Yoga</title><p>
<list list-type="order"><list-item><p>Patients were asked to drink <italic>Ksheera</italic> (milk) till <italic>Akantha Purana</italic> is obtained. Approximately 2-3 l is needed to observe the signs and symptoms of <italic>Akantha Purana</italic>.</p></list-item><list-item><p>Administration of <italic>Jeemutaka Phala</italic> (12 fruits) <italic>Kwatha</italic> with 2 g of <italic>Vacha</italic> (<italic>Acorus calamus</italic>), 1 g of <italic>Saindhava</italic> (Rock salt) and 30 g of <italic>Madhu</italic> (Honey) as <italic>Vamana Yoga</italic>.</p></list-item><list-item><p>About 2-3 l of <italic>Vamanopaga Dravya</italic> i.e. <italic>Yashtimadhu Phanta</italic> (hot infusion of <italic>Glycerrhiza glabra</italic>) was given, followed by administration of <italic>Lavanodaka</italic> (rock salt water).</p></list-item><list-item><p><italic>Dhoompana</italic> was done with <italic>Dashamoola Churna</italic> through the mouth for 3-4 puffs.</p></list-item><list-item><p><italic>Vamana Karma</italic> was followed by <italic>Samsarjana Karma</italic> as per the type of <italic>Shuddhi</italic>.</p></list-item></list></p></sec><sec id="sec3-3"><title>Virechana procedure</title><p>This is same as <italic>Vamana Karma</italic> except that <italic>Koshtha Pareeksha</italic>, <italic>Deepana-Pachana</italic>, and <italic>Kaphotkleshakara Ahara</italic>, which is not done in <italic>Virechana Karma</italic>, whereas <italic>Abhyanga</italic> and <italic>Swedana</italic> were done for 3 days.</p><p>The <italic>Virechana Yoga</italic> [decoction made up of 15 g each of <italic>Aragvadha</italic> (<italic>Cassia fistula</italic>), <italic>Draksha</italic> (<italic>Vitis vinifera</italic>), Haritaki (<italic>Terminalia chebula</italic>) +4 g <italic>Katuki Churana</italic> (<italic>Picrorhiza kurroa</italic>) +30 ml <italic>Eranda Taila</italic> (castor oil) +2 tablets of <italic>Abhayadi Modaka</italic>] was given in empty stomach at 8-10 am.</p><p><italic>Paschat Karma</italic>, same as <italic>Vamana Karma</italic> except <italic>Dhoomapana</italic>.[<xref ref-type="bibr" rid="ref7">7</xref>]</p></sec></sec><sec id="sec2-8"><title>Criteria for assessment of results</title><p>Psoriasis Area and Severity Index[<xref ref-type="bibr" rid="ref8">8</xref>] (PASI) score was considered for both subjective and objective parameters.</p></sec><sec id="sec2-9"><title>Totaling up the index</title><p>For each skin section, add up the three severity scores and multiply the total by the area score, and then multiply that result by percentage of the skin in that section.</p><p>The severity of PASI Parameters (scaling, erythema, and induration) and other parameters were assessed in the following manner.</p><p><graphic xlink:href="Ayu-33-224-g002.jpg" position="float"/></p><p><graphic xlink:href="Ayu-33-224-g003.jpg" position="float"/></p><p>The severity of <italic>Kandu</italic> (itching), <italic>Mandal Rupa</italic> (oval/round patches), <italic>Krodha</italic> (anger), <italic>Shoka</italic>, and <italic>Chinta</italic> (anxiety) was assessed in the following manner:</p><p><graphic xlink:href="Ayu-33-224-g004.jpg" position="float"/></p></sec></sec><sec id="sec1-3"><title>Observations</title><p>Maximum patients were in the age group of 20-30 years and 65% were males, 87.5% belongs to Hindu community, 85% were married and have primary level education, 55% patients had sedentary type of work, 80% were from urban area, 25% have chronicity of more than 5 years and 90% have negative family history of Psoriasis. Majority of patients, (72.5%) were taking allopathic treatment and 12.5% were taking Ayurvedic treatment. 62.5% patients have irregular bowel habits. 50% patients have <italic>Samyak Nidra</italic> and 35% have <italic>Alpa Nidra</italic>. Majority of the patients (97.5%) have gradual onset of the disease. 65% patients have <italic>Viruddha Ahara</italic> with 30% patients taking milk with <italic>Amla</italic> and <italic>Lavana Rasa</italic>. Milk with fish is reported in 7.5% and milk with onion in 10%. <italic>Chinta</italic> was the major <italic>Manasika Nidana</italic> reported by 55% patients followed by <italic>Krodha</italic> in 42.5%, and <italic>Shoka</italic> in 27.5% patients. A total of 70% reported aggravation of symptoms in winter season, 85% each have presented with the lesions o n the legs and torso, 82.5% had lesions on arms, and 75% had lesions on head. 7.5% had lesions on palm and sole and 5% had lesions on scalp. Nobody was observed to have lesions on genitals. Nearly 80% have presented with the plaque type of psoriasis, 10% having guttate psoriasis, and only 5% each having erythrodermic and pustular psoriasis. Nearly 90% have candle grease sign positive whereas Auspitz sign and Koebners phenomenon were found in 62.5% and 10%, respectively.</p><p><italic>Sweta-Rakta Varna</italic> (faint reddish white) was observed in 87.5%, <italic>Sukla Rom-Raji Santanini</italic> (pervaded with white hairline/scale) in 85%, <italic>Kandu</italic> (itching) in 100%, <italic>Sukla Picchala Srava</italic> (thick white and slimy discharge) in 15%, <italic>Utsana Mandala</italic> (raised patches) in 87.5%, and <italic>Ananonya Sansatat Mandal</italic> (patches joined with each other) in 62.5% patients. <italic>Anubandhi Vedana</italic> like <italic>Ati Sweda</italic> (over sweating) in 2.5%, <italic>Asweda</italic> (absence of sweating) in 10%, <italic>Shareera Guruta</italic> (heaviness of the body) in 40%, <italic>Malabaddhata</italic> (constipation) in 50%, <italic>Agni Mandya</italic> (loss of appetite) in 37.5%, <italic>Suptata</italic> (numbness) in 2.5%, and <italic>Toda</italic> (pain) in 10% patients.</p></sec><sec sec-type="results" id="sec1-4"><title>Results</title><sec id="sec2-10"><title>PASI scoring</title><p>In leg total PASI [<xref ref-type="table" rid="T2">Table 2</xref>], torso total PASI [<xref ref-type="table" rid="T3">Table 3</xref>], arm total PASI [<xref ref-type="table" rid="T4">Table 4</xref>], head total PASI [<xref ref-type="table" rid="T5">Table 5</xref>] statistically significant results were noted in all the four groups.</p><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Pattern of clinical improvement in leg total PASI in patients of all the four groups</p></caption><graphic xlink:href="Ayu-33-224-g005"/></table-wrap><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>Pattern of clinical improvement in torso total PASI in patients of all the four groups</p></caption><graphic xlink:href="Ayu-33-224-g006"/></table-wrap><table-wrap id="T4" position="float"><label>Table 4</label><caption><p>Pattern of clinical improvement in arm total PASI in patients of all the four groups</p></caption><graphic xlink:href="Ayu-33-224-g007"/></table-wrap><table-wrap id="T5" position="float"><label>Table 5</label><caption><p>Pattern of clinical improvement in head total PASI in patients of all the four groups</p></caption><graphic xlink:href="Ayu-33-224-g008"/></table-wrap><p>Marked improvement in total PASI was observed in the patients of Group B is (82.70%) and Group D (79.58%), which are both statistically highly significant. Moderate improvement was observed in Group A (58.29%) and Group C (53.70%), which is statistically significant and highly significant, respectively [<xref ref-type="table" rid="T6">Table 6</xref>].</p><table-wrap id="T6" position="float"><label>Table 6</label><caption><p>Pattern of clinical improvement in total PASI in patient of all the four groups</p></caption><graphic xlink:href="Ayu-33-224-g009"/></table-wrap><p>On comparing the effect in all groups; it is clear that the patients from Group B showed maximum percentage relief as compared with other groups. Groups B, C, and D were statistically highly significant.</p><sec id="sec3-4"><title>Kandu</title><p>Moderate improvement in <italic>Kandu</italic> was observed in the patients of Group B (61.11%) and Group D (65.62%), which is statistically significant and highly significant, respectively. Mild improvement was observed in Group A (33.33%) and Group C (37.95%) and are mildly significant and highly significant, respectively.</p><p>On comparing the effect on all groups, it is clear that the patients from Group D showed maximum percentage relief as compared with other groups. Group C and D were statistically highly significant.</p></sec><sec id="sec3-5"><title>Mandala Rupa</title><p>Moderate improvement in <italic>Mandala Rupa</italic> was observed in the patients of Group B (63.33%) and Group D (55.17%), which is statistically highly significant. Mild improvement was observed in Group A (35.48) and Group C (29.62%), which is statistically insignificant and highly significant respectively.</p></sec><sec id="sec3-6"><title>Krodha</title><p>Moderate improvement in <italic>Krodha</italic> was observed in the patients of Group B (57.08%) and Group C (67.00%), which is statistically insignificant. Mild improvement was observed in Group A (42.00%) while minimal improvement in Group D (22.22%), which is significant and insignificant respectively.</p></sec><sec id="sec3-7"><title>Shoka</title><p>Moderate improvement in <italic>Shoka</italic> was observed in the patients of Group A (54.64%), Group B (71.67%), and Group C (60.00%). Group A is statistically significant while Groups B and C both are insignificant.</p></sec><sec id="sec3-8"><title>Chinta</title><p>Moderate improvement in <italic>Chinta</italic> was observed in the patients of Group B (61.08%), Group C (55.55%), and Group D (66.66%). Group B is statistically highly significant whereas Groups C and D are moderately significant. Mild improvement was observed in Group A (41.32%) and is insignificant.</p></sec></sec><sec id="sec2-11"><title>Overall effect of therapy</title><p>
<list list-type="bullet"><list-item><p>In Group A, moderate improvement was observed in 20% patients whereas mild improvement was observed in 80% patients.</p></list-item><list-item><p>In Group B, marked improvement was observed in 10% patients whereas moderate improvement was observed in 90% patients.</p></list-item><list-item><p>In Group C, mild improvement was observed in 100% patients.</p></list-item><list-item><p>In Group D, moderate improvement was observed in 80% patients whereas mild improvement was observed in 20% patients.</p></list-item></list></p><p>No one was observed to have improvement/controlled or minimal/no response toward therapy in any group [<xref ref-type="table" rid="T7">Table 7</xref>].</p><table-wrap id="T7" position="float"><label>Table 7</label><caption><p>Overall effect of therapy in all four groups</p></caption><graphic xlink:href="Ayu-33-224-g010"/></table-wrap></sec><sec id="sec2-12"><title>Recurrence</title><p>After 1 month, 0%, 0%, 28.5%, 10% and after 2 months 25%, 20%, 40%, 37.5% recurrence was found, respectively in A, B, C, D groups.</p></sec></sec><sec sec-type="discussion" id="sec1-5"><title>Discussion</title><p>Changes in life style, irregularities in dietary habits became major issues in current scenario and are responsible in manifesting a number of ailments. Significance of lifestyle and diet, etc., have been well recognized in Ayurvedic classics and emphasis a following the guidelines on <italic>Dinacharya</italic>, <italic>Rutucharya</italic> in eradication of various diseases can be readily observed in them.[<xref ref-type="bibr" rid="ref9">9</xref>-<xref ref-type="bibr" rid="ref14">14</xref>]</p><sec id="sec2-13"><title/><sec id="sec3-9"><title>Deepana and Pachana</title><p><italic>Panchakola Churna</italic> increases the <italic>Agni</italic> and then helps in <italic>Ama Pachana</italic>.</p></sec><sec id="sec3-10"><title>Snehana</title><p><italic>Snehapana</italic> with <italic>Panchatikta Ghrita</italic> as a <italic>Purvakarma</italic> subsides the symptoms like <italic>Rukshata</italic>, <italic>Daha</italic>, etc., Similarities in chemical and physiological nature in <italic>Ghrita</italic> and human cell membrane intensifies the penetration of <italic>Sneha</italic> (<italic>Panchatikta Ghrita</italic>) in to deeper tissues causing partial rejuvenation of cell, smoothing of vitiated <italic>Dosha</italic> (stagnated metabolic wastes).</p></sec><sec id="sec3-11"><title>Vamana and Virechana</title><p>Soothened <italic>Doshas</italic> will get liquefied and reaches to <italic>Koshtha</italic> by <italic>Swedana</italic>, which can be easily eliminated by the action of <italic>Vamana</italic> and <italic>Virechana</italic>.</p><p>Thus it is clear that the toxins or nitrogenous waste materials that are collected in lower intestinal cells are removed by <italic>Virechana</italic> and thus cleansing the lower passage and rejuvenating each and every cell of lower GIT.</p><p>These <italic>Shodhana</italic> (<italic>Vamana</italic> and <italic>Virechana</italic>) probably may leads to certain endogeneous changes in the body responsible for the alleviation of psoriatic pathological process.</p></sec></sec><sec id="sec2-14"><title>Dermo-care (<italic>Kalpit Yoga</italic>)</title><p>Most of these drugs have following properties &#x02013; <italic>Kushthaghna, Krimighna, Rakta Shodhana, Kandughna, Amapachana, Medhya, Rasayana, Kaphaghna, Twachya, Yakriduttejaka, Agni Vardhak</italic>, and also <italic>Tridoshaghna</italic>. The synergistic actions of <italic>Tikta</italic> and <italic>Kashaya Rasa</italic> dominant herbs and minerals are likely to check the etio-pathogenesis of <italic>Mandal Kushtha</italic> (Psoriasis) and arrest its progress.</p></sec></sec><sec sec-type="conclusion" id="sec1-6"><title>Conclusion</title><p><italic>Vamana</italic> and <italic>Virechana</italic> along with Dermo-Care proved more effective to control erythema of leg and arm; induration of leg, torso, arm, and head; scales of leg, torso, and head; coverage area of torso and arm; <italic>Mandal Rupa</italic> and <italic>Shoka</italic>. Only Dermo-Care is more effective to control <italic>Krodha</italic>. Neotrexate (Methotrexate) is more effective to control erythema in torso and head; scales in arm; coverage area of leg and head; <italic>Kandu</italic> and <italic>Chinta</italic>. <italic>Shodhana</italic> independently have shown much better results than the patients treated with <italic>Shamana</italic> therapy (Dermo-care yoga). Neotrexate (Methotrexate) independently have shown much better results than the patients treated with <italic>Shodhana</italic> alone or <italic>Shamana</italic> therapy (Dermo-care) alone. <italic>Shodhana</italic> followed by <italic>Shamana</italic> therapy have shown better results than the patients treated with <italic>Shodhana</italic>, <italic>Shamana</italic> therapy or modern medicine alone.</p></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Meffert</surname><given-names>J Psoriasis</given-names></name></person-group><date-in-citation>Updated on 2012 Aug 6</date-in-citation><comment>Available from: <uri xlink:type="simple" xlink:href="http://emedicinemedscapecom/article/1943419-overview">http://emedicinemedscapecom/article/1943419-overview</uri></comment></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Anthony</surname><given-names>S</given-names></name><name><surname>Braunwald</surname><given-names>E</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name><name><surname>Hauser</surname><given-names>SL</given-names></name><name><surname>Longo</surname><given-names>DL</given-names></name><name><surname>Jameson</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Eczema, psoriasis, cutaneous infections, acne, and other common skin disorders in Harrison&#x02019;s Principles of Internal Medicine</article-title><year>2008</year><edition>17st ed</edition><publisher-loc>New York</publisher-loc><publisher-name>McGraw Hill Publication, McGraw-Hill Medical</publisher-name><fpage>517</fpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname><given-names/></name><name><surname>Charaka</surname><given-names/></name><name><surname>Dridhabala</surname><given-names/></name><name><surname>Charaka</surname><given-names>Samhita</given-names></name><name><surname>Sutra</surname><given-names>Sthana</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Jadavaji</surname><given-names>Vaidya</given-names></name><name><surname>Aacharya</surname><given-names>Trikamji</given-names></name></person-group><year>2000</year><volume>16/20</volume><edition>1st ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Krishnadas Acadamy</publisher-name><fpage>97</fpage></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><collab>Ibidem</collab><person-group person-group-type="author"><name><surname>Charaka</surname><given-names>Samhita</given-names></name><name><surname>Siddhi</surname><given-names>Sthana</given-names></name></person-group><volume>11/12</volume></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Hemadri</surname><given-names/></name><name><surname>Astanga</surname><given-names>Hridaya</given-names><suffix>Commentator</suffix></name><name><surname>Sutra</surname><given-names>Sthana</given-names></name></person-group><year>1995</year><volume>16/19</volume><publisher-loc>Varanasi</publisher-loc><publisher-name>Krishna Das Academy</publisher-name><fpage>247</fpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Govindnath</surname><given-names>Sen</given-names></name><name><surname>Bhaisajya</surname><given-names>Ratnavali</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Kaviraj Shri Ambikadatt</given-names></name><name><surname>Kushtha</surname><given-names>Rogadhikara</given-names></name></person-group><year>2002</year><volume>54/257</volume><edition>15th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukamba Sanskrit Sansthan</publisher-name><fpage>633</fpage></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname><given-names/></name><name><surname>Charaka</surname><given-names/></name><name><surname>Dridhabala</surname><given-names/></name><name><surname>Charaka</surname><given-names>Samhita</given-names></name><name><surname>Sutra</surname><given-names>Sthana</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Aacharya</surname><given-names>Vaidya Jadavaji Trikamji</given-names></name></person-group><year>2000</year><volume>24/18</volume><edition>1st ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Krishnadas Acadamy</publisher-name><fpage>125</fpage></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feldman</surname><given-names>SR</given-names></name><name><surname>Krueger</surname><given-names>GG</given-names></name></person-group><article-title>Psoriasis assessment tools in clinical trials</article-title><source>Ann Rheum Dis</source><year>2005</year><fpage>65</fpage><lpage>8</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kaviraj Atridev</surname><given-names>Gupt</given-names></name><name><surname>Ashtanga</surname><given-names>Hridaya</given-names></name><name><surname>Sutra</surname><given-names>Sthana</given-names></name></person-group><year>2005</year><volume>2/48</volume><edition>1st ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Choukhamba Sanskrit Sansthan</publisher-name><fpage>26</fpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Agnivesha</surname><given-names/></name><name><surname>Charaka</surname><given-names/></name><name><surname>Dridhabala</surname><given-names/></name><name><surname>Charaka</surname><given-names>Samhita</given-names></name><name><surname>Sutra</surname><given-names>Sthana</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Aacharya</surname><given-names>Vaidya Jadavaji Trikamji</given-names></name></person-group><year>2000</year><volume>5/13</volume><edition>1st ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Krishnadas Acadamy</publisher-name><fpage>38</fpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><collab>Ibidem</collab><person-group person-group-type="author"><name><surname>Charaka</surname><given-names>Samhita</given-names></name><name><surname>Chikitsa</surname><given-names>Sthana</given-names></name></person-group><volume>450</volume><issue>7/4-8</issue></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><collab>Ibidem</collab><person-group person-group-type="author"><name><surname>Charaka</surname><given-names>Samhita</given-names></name><name><surname>Nidana</surname><given-names>Sthana</given-names></name></person-group><volume>5/6</volume><issue>217</issue></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sushruta</surname><given-names/></name><name><surname>Sushruta</surname><given-names>Samhita</given-names></name><name><surname>Chikitsa</surname><given-names>Sthana</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Shastri</surname><given-names>Kaviraj Ambikadutta</given-names></name></person-group><year>2001</year><volume>9/2</volume><edition>12th ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Chaukhamba Sanskrit Sansthan</publisher-name><fpage>629</fpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kaviraj Atridev</surname><given-names>Gupt</given-names></name><name><surname>Ashtanga</surname><given-names>Hridaya</given-names></name><name><surname>Nidana</surname><given-names>Sthana</given-names></name></person-group><year>2005</year><volume>14/1-3</volume><edition>1st ed</edition><publisher-loc>Varanasi</publisher-loc><publisher-name>Choukhamba Sanskrit Sansthan</publisher-name><fpage>271</fpage></element-citation></ref></ref-list></back></article>